These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23460744)

  • 21. Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.
    Sui Y; Frey B; Wang Y; Billeskov R; Kulkarni S; McKinnon K; Rourke T; Fritts L; Miller CJ; Berzofsky JA
    PLoS Pathog; 2017 May; 13(5):e1006395. PubMed ID: 28498847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α-Deficiency in Myeloid Cells Leads to a Disturbed Accumulation of Myeloid Derived Suppressor Cells (MDSC) During Pregnancy and to an Increased Abortion Rate in Mice.
    Köstlin-Gille N; Dietz S; Schwarz J; Spring B; Pauluschke-Fröhlich J; Poets CF; Gille C
    Front Immunol; 2019; 10():161. PubMed ID: 30804946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function.
    Köstlin N; Schoetensack C; Schwarz J; Spring B; Marmé A; Goelz R; Brodbeck G; Poets CF; Gille C
    Front Immunol; 2018; 9():1098. PubMed ID: 29868036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.
    Chen S; Akbar SM; Abe M; Hiasa Y; Onji M
    Clin Exp Immunol; 2011 Oct; 166(1):134-42. PubMed ID: 21762128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.
    Haverkamp JM; Crist SA; Elzey BD; Cimen C; Ratliff TL
    Eur J Immunol; 2011 Mar; 41(3):749-59. PubMed ID: 21287554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy.
    Raber PL; Sierra RA; Thevenot PT; Shuzhong Z; Wyczechowska DD; Kumai T; Celis E; Rodriguez PC
    Oncotarget; 2016 Apr; 7(14):17565-78. PubMed ID: 27007050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.
    Dufait I; Schwarze JK; Liechtenstein T; Leonard W; Jiang H; Escors D; De Ridder M; Breckpot K
    Oncotarget; 2015 May; 6(14):12369-82. PubMed ID: 25869209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The proportion and function of peripheral myeloid-derived suppressor cells do not correlate with systemic inflammation in chronic obstructive pulmonary disease.
    Tan DB; Fernandez S; Price P; Moodley YP
    Hum Immunol; 2014 Jan; 75(1):5-9. PubMed ID: 24090682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.
    van der Voort R; Volman TJ; Verweij V; Linssen PC; Maas F; Hebeda KM; Dolstra H
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):378-86. PubMed ID: 23266741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
    Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
    Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
    J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.
    Kohanbash G; McKaveney K; Sakaki M; Ueda R; Mintz AH; Amankulor N; Fujita M; Ohlfest JR; Okada H
    Cancer Res; 2013 Nov; 73(21):6413-23. PubMed ID: 24030977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.
    Hegde VL; Nagarkatti M; Nagarkatti PS
    Eur J Immunol; 2010 Dec; 40(12):3358-71. PubMed ID: 21110319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells.
    Michel A; Schüler A; Friedrich P; Döner F; Bopp T; Radsak M; Hoffmann M; Relle M; Distler U; Kuharev J; Tenzer S; Feyerabend TB; Rodewald HR; Schild H; Schmitt E; Becker M; Stassen M
    J Immunol; 2013 Jun; 190(11):5534-44. PubMed ID: 23636054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
    Wang J; De Veirman K; Faict S; Frassanito MA; Ribatti D; Vacca A; Menu E
    J Pathol; 2016 Jun; 239(2):162-73. PubMed ID: 26956697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes.
    Watanabe S; Deguchi K; Zheng R; Tamai H; Wang LX; Cohen PA; Shu S
    J Immunol; 2008 Sep; 181(5):3291-300. PubMed ID: 18714001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-1 Blockade Reinvigorates Bone Marrow CD8
    Kwon M; Kim CG; Lee H; Cho H; Kim Y; Lee EC; Choi SJ; Park J; Seo IH; Bogen B; Song IC; Jo DY; Kim JS; Park SH; Choi I; Choi YS; Shin EC
    Clin Cancer Res; 2020 Apr; 26(7):1644-1655. PubMed ID: 31941832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.
    De Veirman K; De Beule N; Maes K; Menu E; De Bruyne E; De Raeve H; Fostier K; Moreaux J; Kassambara A; Hose D; Heusschen R; Eriksson H; Vanderkerken K; Van Valckenborgh E
    Cancer Immunol Res; 2017 Oct; 5(10):839-846. PubMed ID: 28903971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.
    Bailur JK; McCachren SS; Doxie DB; Shrestha M; Pendleton K; Nooka AK; Neparidze N; Parker TL; Bar N; Kaufman JL; Hofmeister CC; Boise LH; Lonial S; Kemp ML; Dhodapkar KM; Dhodapkar MV
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.